Mice with human astrocytes performed better on memory experiments than those that had received
mouse cell grafts, the team reports today in Cell Stem Cell.
Not exact matches
This study, «Engineered epidermal progenitor
cells can correct diet - induced obesity and diabetes,» is the first to show that an engineered skin
graft can survive long term in wild - type
mice with intact immune systems.
They mixed the
cells into a jelly - like matrix and applied the
grafts to
mice.
A decade ago, he replicated the entire human leukemia disease process by introducing oncogenes into normal human blood
cells, transplanting them into xenografts (special immune - deficient
mice that accept human
grafts) and watching leukemia develop — a motherlode discovery that has guided leukemia research ever since.
The team tested its technique on three
mice whose abdomens had been
grafted with
cells from human brain cancer.
When
grafted onto bald
mice, the
cells produced not only furry tufts but stretches of skin complete with the oil - producing glands that help keep it supple as well.
The researchers then extracted the
cells and
grafted them onto genetically engineered hairless
mice.
The researchers found that PAI - 039 inhibited the migration of cultured human coronary artery smooth muscle
cells, and prevented the development of blockages in arteries and bypass
grafts in
mice.
Researchers from Japan's RIKEN institute announced in April that they have grown skin from
mouse stem
cells in a process that one day may help skin
graft recipients.
In tests on human breast cancer
cells and in special immunodeficient
mice with tissue
grafts, the scientists found that both agents interfered with genes involved with breast cancer
cell growth, resulting in more cancer
cells.
To do this, they switched from using dead tumour
cell samples to patient - derived tumour
cell lines, in which fresh samples of a person's tumour are
grafted onto
mice and grown to the required volumes.
The research team tested the hypothesis by transplanting
cells onto the surface of
mouse bone
grafts and studying the
cell behavior both in vivo — inside the animal — and in vitro — outside the body.
A stem
cell - derived neuron
grafted onto a
mouse cochlea in the inner ear that lacked neurons.
The current research team, which includes Dr. Minoda and Dr. Hiroki Takeda of Kumamoto University, and several researchers from Keio University, have successfully
grafted human iPS - derived
cells into the inner ear of embryonic
mice, a feat with a high level of technical difficulty.
The team conducted investigations by
grafting low - metastatic (LM) and high - metastatic (HM) melanoma tumour
cells under the skin of
mice.
The fact that Connexin 30 knockout
mice had a higher number of
grafted cells than normal
mice, and that some of the
grafted cells expressed CONNEXIN 30 is a very important finding when considering
cell transplantation as a treatment for hereditary hearing loss caused by CONNEXIN deficiency.
Human egg
cells behaved the same way; when human ovary tissue was
grafted into
mice injected with PAH, the eggs died, the team reports in Nature Genetics online this month.
However, the Connexin 30 knockout
mice had more
grafted cells than the normal
mice, and some of the
grafted cells were found to express CONNEXIN 30.
Furthermore, this study revealed that
cells derived from humans can be
grafted into the heterozygous inner ear of
mouse embryos.
While humanized
mouse models for HIV infection have utility, the model is limited due to incomplete immune reconstitution, development of xenogeneic
graft versus host disease (GVHD), and the absence of normal T
cell homeostasis.
As expected, xenogeneic
graft versus host disease (GVHD), assessed clinically by dermatitis and hair loss, was observed in
mice receiving
cells treated with both R5 - ZFNs and X4 - ZFNs in the absence of HIV challenge.
However, closer scrutiny of these studies raises questions about the role of CD4 + T
cells as the sole mediators of corneal
graft rejection, as corneal allografts undergo immune rejection in 33 % of the
mice and 64 % of the rats treated with anti-CD4 monoclonal antibody (12, 13) and in 45 % of the CD4 KO
mice (14).
Short term T -
cell mediated immune response blockade promotes the functionality of hESC - derivative
grafts in immune - competent
mice.
Support
cells generated from patients with childhood onset schizophrenia stunted neural circuit development when
grafted into developing
mouse brains.
Creation of a rich subcutaneous vascular network with implanted adipose tissue - derived stromal
cells and adipose tissue enhances subcutaneous
grafting of islets in diabetic
mice.
Scientists
grafted genetically edited human skin
cells to treat type - 2 diabetes and prevent obesity in
mice.
Interestingly, when we looked at the splenocytes in these
mice and compared them to controls, we were not able to detect a significant difference in the numbers of Tregs, suggesting that in the transplant model, Tregs may be within the
graft - infiltrating population where they could regulate infiltrating host T
cells.
To help determine how long a bone marrow (stem
cell)
graft will last, researchers at Sanford - Burnham Medical Research Institute (Sanford - Burnham) have developed a mathematical model that predicts how long a stem
cell will live and tested those predictions in a
mouse model.
Two new NSG
mouse models allow immunological dissection of
graft - versus - host disease (GVHD) responses and in vivo testing of therapeutic agents targeting human CD4 T
cells.